M Peña Chilet-rekin lankidetzan egindako argitalpenak (12)

2020

  1. HDAC5 inhibitors as a potential treatment in breast cancer affecting very young women

    Cancers, Vol. 12, Núm. 2

  2. miRNA Expression Analysis: Cell Lines HCC1500 and HCC1937 as Models for Breast Cancer in Young Women and the miR-23a as a Poor Prognostic Biomarker

    Breast Cancer: Basic and Clinical Research, Vol. 14

2019

  1. Acceleration in the DNA methylation age in breast cancer tumours from very young women

    Scientific Reports, Vol. 9, Núm. 1

  2. Breast Cancer in Very Young Patients in a Spanish Cohort: Age as an Independent Bad Prognostic Indicator

    Breast Cancer: Basic and Clinical Research, Vol. 13

2018

  1. Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women

    Scientific Reports, Vol. 8, Núm. 1

2014

  1. Long telomere length and a TERT-CLPTM1 locus polymorphism association with melanoma risk

    European Journal of Cancer, Vol. 50, Núm. 18, pp. 3168-3177

  2. MicroRNA profile in very young women with breast cancer

    BMC Cancer, Vol. 14, Núm. 1

2013

  1. Genetic variants in PARP1 (rs3219090) and IRF4 (rs12203592) genes associated with melanoma susceptibility in a Spanish population

    BMC Cancer, Vol. 13

  2. High stability of microRNAs in tissue samples of compromised quality

    Virchows Archiv, Vol. 463, Núm. 6, pp. 765-774

  3. rs12512631 on the Group Specific Complement (Vitamin D-Binding Protein GC) Implicated in Melanoma Susceptibility

    PLoS ONE, Vol. 8, Núm. 3

2011

  1. A customized pigmentation snp array identifies a novel snp associated with melanoma predisposition in the slc45a2 gene

    PLoS ONE, Vol. 6, Núm. 4

  2. Genetic polymorphisms in DNA repair and oxidative stress pathways associated with malignant melanoma susceptibility

    European Journal of Cancer, Vol. 47, Núm. 17, pp. 2618-2625